# Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients

> **NCT01714960** · PHASE1 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 70 (actual)

## Conditions studied

- Healthy Volunteers and Glaucoma Patients

## Interventions

- **DRUG:** MRZ-99030 eye drops 5mg/mL
- **DRUG:** MRZ-99030 eye drops 20mg/mL
- **DRUG:** Placebo to MRZ-99030 eye drops

## Key facts

- **NCT ID:** NCT01714960
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01714960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01714960, "Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01714960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*